Atlas FDA

Portico™ Transcatheter Heart Valve

FDA premarket approval P190023/S004 · decided 2021-12-16

Approval details

PMA number
P190023
Supplement
S004
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Portico™ Transcatheter Heart Valve
Generic name
Aortic valve, prosthesis, percutaneously delivered
Applicant
ABBOTT MEDICAL
Date received
2021-11-08
Decision date
2021-12-16
Days to decision
38 days
Decision code
OK30
Product code
NPT
Advisory committee
Cardiovascular
Expedited review
No
Location
St. Paul, MN
Statement
Discontinuation of passive monitoring procedures in ISO Class 7 and 8 cleanrooms.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
EnSite™ X EP System (K262006)Abbott Medical2026-07-15
Amplatzer TorqVue Exchange System (K261631)Abbott Medical2026-06-17
OPTIS Mobile Next Imaging System (1014932); OPTIS Integrated Next Imaging System (1014933); Ultreon 3.0 Software Upgrade Kit (ULTR300001) (K253459)ABBOTT MEDICAL2026-04-24
EnSite™ X EP System (K260212)ABBOTT MEDICAL2026-04-20
Disposable Radiofrequency Cannula (K253907)ABBOTT MEDICAL2026-04-16
Amplatzer™ Trevisio™ Intravascular Delivery System; 9-ATV06F45/609-ATV07F45/609-ATV07F45/809-ATV08F45/609-ATV08F45/809-ATV09F45/809-ATV10F45/809-ATV12F45/80 (K260499)ABBOTT MEDICAL2026-03-13
Armada™ 14 NC PTA Catheter (K252512)ABBOTT MEDICAL2026-02-13
Assert-IQ (DM5100) (K253516)ABBOTT MEDICAL2025-12-18